by
Akane Naka, Project Manager | April 17, 2007
Topics
1. Pathophysiology of Diabetes and Dyslipidemia: New Perspectives on Old Mechanisms
2. Treating Hyperglycemia and Dyslipidemia in People with Diabetes: Achieving Optimal Treatment Targets
Ad Statistics
Times Displayed: 51729
Times Visited: 1518 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
3. A Clinical Approach to Achieving Treatment Targets: Case Vignettes
Learning Objectives
Participants will be provided with clinically relevant, evidence-based information. Upon completion of this activity, the participant should be able to:
* Describe the long-term vascular implications of diabetes
* Identify appropriate treatment targets for key components of the metabolic syndrome, particularly the hyperglycemia of type 2 diabetes and accompanying dyslipidemia
* Design and initiate comprehensive preventive and treatment strategies focused on achieving targeted glycemia and lipid levels to reduce cardiovascular risk and the incidence of macrovascular complications in people with diabetes
* Implement glucose-control and lipid-control strategies in people who have obstacles to treatment (including medication contraindications or adverse experiences) to effectively approach recommended treatment targets
Faculty
Peter N. Weissman, MD
Program Moderator
Associate Clinical Professor of Medicine and Endocrinology
Miller School of Medicine
University of Miami
Miami, FL
Ishwarlal Jialal MD, PhD
Robert E. Stowell Endowed Chair in Experimental Pathology
Director of the Laboratory for Atherosclerosis and Metabolic Research,
Professor of Internal Medicine
UC Davis Medical Center
Sacramento, CA
Accreditation and Designation of Credit
The Joslin Diabetes Center, Boston is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Joslin Diabetes Center designates this educational activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This CME activity was planned and produced in accordance with ACCME Essentials.
Participants not eligible for continuing medical education credit will receive a certificate of participation.
Click here to search for the symposium near you:
Joslin CME Activities
Thia information is reposted with thanks to Joslin Diabetes Center.
Back to HCB News
